Fusion with extracellular domain of cytotoxic T-lymphocyte-associated- antigen 4 leads to enhancement of immunogenicity of Hantaan virus DNA vaccines in C57BL/6 mice

Virology Journal

Volumn 8, Issue , 2011, Pages

  Liu, Feng ^a   Liang, Mifang ^a   Cao, Shouchun ^a   Liu, Qinzhi ^a   Zhang, Quanfu ^a   Li, Chuan ^a   Zhang, Shuo ^a   Wang, Shiwen ^a   Li, Dexin ^a  

^a NATIONAL INSTITUTE FOR VIRAL DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EXTRACELLULAR DOMAIN OF CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 HANTAAN GLYCOPROTEIN FUSION PROTEIN; EXTRACELLULAR DOMAIN OF CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 HANTAAN VIRUS NUCLEOCAPSID FUSION PROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE; ABATACEPT; ANTIBODY CONJUGATE; CAPSID PROTEIN; CORE PROTEIN; HYBRID PROTEIN; NUCLEOCAPSID PROTEIN, HANTAAN VIRUS; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL STRAIN BHK; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; FEMALE; HANTAVIRUS; IMMUNOGENICITY; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECOMBINANT PLASMID; VACCINE PRODUCTION; VIRAL GENE DELIVERY SYSTEM; VIRUS NEUTRALIZATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CHEMISTRY; FLOW CYTOMETRY; GENETICS; HAMSTER; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLISM; PLASMID; SIGNAL TRANSDUCTION; VACCINATION; VIROLOGY;

ANIMALIA; HANTAAN VIRUS; MUS; RODENTIA;

ANIMALS; ANTIBODIES, VIRAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, VIRAL; CAPSID PROTEINS; CELL LINE; CPG ISLANDS; CRICETINAE; FEMALE; FLOW CYTOMETRY; HANTAAN VIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; IMMUNOCONJUGATES; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED C57BL; PLASMIDS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA; VIRAL CORE PROTEINS;

EID: 80053172788     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-448     Document Type: Article

References (42)

1. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Peters CJ, Simpson GL, Levy H, Annu Rev Med 1999 50 531 545 10.1146/annurev.med.50.1.531 10073292 (Pubitemid 29117081)
2. Hantaviruses: a global disease problem. Schmaljohn C, Hjelle B, Emerg Infect Dis 1997 3 95 104 10.3201/eid0302.970202 9204290 (Pubitemid 127431667)
3. Hemorrhagic fever with renal syndrome. Lee HW, van der Groen G, Prog Med Virol 1989 36 62 102 2573914
4. Epidemiology and pathogenesis of hemorrhagic fever with renal syndrome. Lee H, The Bunyaviridae 1996 253 267
5. Vaccines against hantaviruses. Hjelle B, Expert Rev Vaccines 2002 1 373 384 10.1586/14760584.1.3.373 12901576 (Pubitemid 36559872)
6. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection. Hooper JW, Kamrud KI, Elgh F, Custer D, Schmaljohn CS, Virology 1999 255 269 278 10.1006/viro.1998.9586 10069952 (Pubitemid 29393338)
7. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters. Kamrud KI, Hooper JW, Elgh F, Schmaljohn CS, Virology 1999 263 209 219 10.1006/viro.1999.9961 10544095 (Pubitemid 29493631)
8. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. Hooper JW, Custer DM, Thompson E, Schmaljohn CS, J Virol 2001 75 8469 8477 10.1128/JVI.75.18.8469-8477.2001 11507192 (Pubitemid 32768951)
9. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Boyle JS, Brady JL, Lew AM, Nature 1998 392 408 411 10.1038/32932 9537327 (Pubitemid 28168740)
10. T-cell regulation by CD28 and CTLA-4. Alegre ML, Frauwirth KA, Thompson CB, Nat Rev Immunol 2001 1 220 228 10.1038/35105024 11905831 (Pubitemid 33741960)
11. The emerging role of CTLA-4 as an immune attenuator. Thompson CB, Allison JP, Immunity 1997 7 445 450 9354465 (Pubitemid 27508696)
12. CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas. Hueber AJ, Matzkies FG, Rahmeh M, Manger B, Kalden JR, Nagel T, Immunol Cell Biol 2006 84 51 58 10.1111/j.1440-1711.2005.01402.x 16405652
13. Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks. Lu M, Isogawa M, Xu Y, Hilken G, J Virol 2005 79 6368 6376 10.1128/JVI.79.10.6368-6376.2005 15858020 (Pubitemid 40617240)
14. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Mutwiri G, Pontarollo R, Babiuk S, Griebel P, van Drunen Littel-van den Hurk S, Mena A, Tsang C, Alcon V, Nichani A, Ioannou X, Gomis S, Townsend H, Hecker R, Potter A, Babiuk LA, Vet Immunol Immunopathol 2003 91 89 103 10.1016/S0165-2427(02)00246-5 12543546 (Pubitemid 36113256)
15. Use of CpG oligodeoxynucleotides as immune adjuvants. Klinman DM, Currie D, Gursel I, Verthelyi D, Immunol Rev 2004 199 201 216 10.1111/j.0105-2896.2004. 00148.x 15233736 (Pubitemid 38736773)
16. Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Weeratna R, Brazolot Millan CL, Krieg AM, Davis HL, Antisense Nucleic Acid Drug Dev 1998 8 351 356 10.1089/oli.1.1998.8.351 9743472 (Pubitemid 28446121)
17. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Kojima Y, Xin KQ, Ooki T, Hamajima K, Oikawa T, Shinoda K, Ozaki T, Hoshino Y, Jounai N, Nakazawa M, Klinman D, Okuda K, Vaccine 2002 20 2857 2865 10.1016/S0264-410X(02) 00238-4 12126895 (Pubitemid 34785954)
18. CpG motifs are efficient adjuvants for DNA cancer vaccines. Schneeberger A, Wagner C, Zemann A, Luhrs P, Kutil R, Goos M, Stingl G, Wagner SN, J Invest Dermatol 2004 123 371 379 10.1111/j.0022-202X.2004.23208.x 15245438 (Pubitemid 38951833)
19. Study on transmission of epidemic hemorrhagic fever virus via human placenta and localization in multi-organs of fetus. Yang WS, Bai XG, Zhang WB, Wang AL, Bai XF, Chen SY, He YL, Chinese journal of public health 1987 2 85 89
20. Antigenic and molecular characterization of hantavirus isolates from China. Liang M, Li D, Xiao SY, Hang C, Rossi CA, Schmaljohn CS, Virus Res 1994 31 219 233 10.1016/0168-1702(94)90005-1 7909976 (Pubitemid 24063723)
21. Serological characterization of a hantavirus from Hubei, China. Xu FL, Yang ZQ, Yang CC, Xiao SY, Xiao H, Wen L, Acta Virol 2004 48 5 8 15230468
22. Molecular cloning, nucleotides sequence and transient expression of S and M genome segment of hantavirus strain 84Fli. Liu Z, Li D, Li C, Wang X, Meng X, Liang M, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2002 16 48 51 11986746
23. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice. Li C, Liu F, Liang M, Zhang Q, Wang X, Wang T, Li J, Li D, Vaccine 2010 28 4294 4300 10.1016/j.vaccine.2010.04.025 20433802
24. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection. Bernstein DI, Tepe ER, Mester JC, Arnold RL, Stanberry LR, Higgins T, Vaccine 1999 17 1964 1969 10.1016/S0264-410X(98)00469-1 10217595 (Pubitemid 29172366)
25. Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling. Shimosato T, Kitazawa H, Katoh S, Tohno M, Iliev ID, Nagasawa C, Kimura T, Kawai Y, Saito T, Biochem Biophys Res Commun 2005 326 782 787 10.1016/j.bbrc.2004.11.119 15607737 (Pubitemid 39655987)
26. Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine. Yoo YC, Yoshimatsu K, Koike Y, Hatsuse R, Yamanishi K, Tanishita O, Arikawa J, Azuma I, Vaccine 1998 16 216 224 10.1016/S0264-410X(97)00188-6 9607033 (Pubitemid 27521001)
27. A novel mu-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome. Zoller LG, Yang S, Gott P, Bautz EK, Darai G, J Clin Microbiol 1993 31 1194 1199 8099085 (Pubitemid 23129443)
28. Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain. Liang M, Mahler M, Koch J, Ji Y, Li D, Schmaljohn C, Bautz EK, J Med Virol 2003 69 99 107 10.1002/jmv.10259 12436484 (Pubitemid 35403660)
29. Human recombinant neutralizing antibodies against hantaan virus G2 protein. Koch J, Liang M, Queitsch I, Kraus AA, Bautz EK, Virology 2003 308 64 73 10.1016/S0042-6822(02)00094-6 12706090 (Pubitemid 36428965)
30. DNA vaccines for viral diseases. Davis HL, McCluskie MJ, Microbes Infect 1999 1 7 21 10.1016/S1286-4579(99)80009-4 10594972 (Pubitemid 29364907)
31. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW, J Virol 2003 77 9894 9905 10.1128/JVI.77.18.9894-9905.2003 12941899 (Pubitemid 37122070)
32. Vaccines against hantaviruses. Hooper JW, Li D, Curr Top Microbiol Immunol 2001 256 171 191 10.1007/978-3-642-56753-7-10 11217404 (Pubitemid 32016378)
33. Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Bharadwaj M, Lyons CR, Wortman IA, Hjelle B, Vaccine 1999 17 2836 2843 10.1016/S0264-410X(99)00096-1 10438054 (Pubitemid 29323010)
34. Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus). Bharadwaj M, Mirowsky K, Ye C, Botten J, Masten B, Yee J, Lyons CR, Hjelle B, J Gen Virol 2002 83 Pt 7 1745 51 12075094 (Pubitemid 34716281)
35. DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection. Koletzki D, Schirmbeck R, Lundkvist A, Meisel H, Kruger DH, Ulrich R, J Biotechnol 2001 84 73 78 11035190
36. The human IgG3 hinge mediates the formation of antigen dimers that enhance humoral immune responses to DNA immunisation. Drew DR, Boyle JS, Lew AM, Lightowlers MW, Strugnell RA, Vaccine 2001 19 4115 4120 10.1016/S0264-410X(01) 00182-7 11457535 (Pubitemid 32703630)
37. Enhanced immunogenicity of human papillomavirus 16 L1 genetic vaccines fused to an ER-targeting secretory signal peptide and RANTES. Kim SJ, Lee C, Lee SY, Kim I, Park JS, Sasagawa T, Ko JJ, Park SE, Oh YK, Gene Ther 2003 10 1268 1273 10.1038/sj.gt.3301997 12858192 (Pubitemid 36934729)
38. Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand. Sailaja G, Husain S, Nayak BP, Jabbar AM, J Immunol 2003 170 2496 2507 12594275 (Pubitemid 36245639)
39. Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4. Nayak BP, Sailaja G, Jabbar AM, J Virol 2003 77 10850 10861 10.1128/JVI.77.20.10850-10861.2003 14512535 (Pubitemid 37204278)
40. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy. Kennedy NJ, Spithill TW, Tennent J, Wood PR, Piedrafita D, Vaccine 2006 24 970 979 10.1016/j.vaccine. 2005.08.076 16242220 (Pubitemid 43185315)
41. A Toll-like receptor recognizes bacterial DNA. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S, Nature 2000 408 740 745 10.1038/35047123 11130078 (Pubitemid 32015992)
42. CpG motifs in bacterial DNA and their immune effects. Krieg AM, Annu Rev Immunol 2002 20 709 760 10.1146/annurev.immunol.20.100301.064842 11861616 (Pubitemid 34293438)